Loading company…
Shenzhen-based maker of minimally invasive laser diagnostic and treatment devices, including intravascular OCT imaging systems.
Based in Shenzhen, China, Vivolight, operating as Shenzhen Vivolight Medical Device & Technology Co., Ltd., develops and manufactures minimally invasive interventional diagnostic and therapeutic devices based on medical laser technology, including intravascular OCT imaging systems. Its OCT system received NMPA approval in April 2020, and a Multimodality OCT System was approved in December 2021. The company closed a Series E round in May 2026 co-led by China-US Green Yangtze River Delta and Efung Capital, with participation from Boc Private Equity Firm and Huiyu Private Equity Fund Management (Huzhou), to fund global commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in